In a 62‑year‑old male with hypertension, peripheral neuropathy, chronic lower‑extremity edema, hyperglycemia (random glucose 235 mg/dL), and a progressively enlarging, foul‑smelling ulcer on the medial left ankle with surrounding erythema, warmth, tenderness, intermittent fever, and serous discharge, what is the most likely diagnosis and appropriate management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diabetic Foot Infection with Underlying Undiagnosed Type 2 Diabetes Mellitus

This patient has a diabetic foot infection (DFI) complicating a previously undiagnosed case of type 2 diabetes mellitus, requiring immediate initiation of culture-directed antibiotics, surgical debridement, pressure off-loading, glycemic control, and urgent multidisciplinary team referral. 1

Primary Diagnosis

Diabetic foot infection (DFI) with underlying type 2 diabetes mellitus. The constellation of findings—random glucose 235 mg/dL, polyuria, polydipsia, nocturia, bilateral peripheral neuropathy (absent vibration sense, reduced light touch and pain sensation), chronic lower extremity edema with skin changes (hyperpigmentation, thickening, eczematous changes), and a progressively enlarging ulcer with purulent discharge, foul odor, surrounding erythema, warmth, and intermittent fever—definitively establishes this diagnosis. 1, 2

The clinical presentation meets DFI criteria: inflammatory signs (erythema, warmth, tenderness, purulent discharge) involving a foot wound below the malleoli. 1 The foul-smelling ("patay na daga") purulent discharge with surrounding cellulitis extending beyond ulcer margins indicates moderate-to-severe infection. 1

Critical Pathophysiologic Triad

This case demonstrates the classic causal pathway for diabetic foot ulceration and subsequent infection:

  • Peripheral neuropathy (absent vibration sense, 50-70% reduction in light touch/pain sensation bilaterally) eliminated protective sensation, allowing unrecognized minor trauma 3
  • Foot deformity/biomechanical stress from prolonged occupational standing created repetitive pressure points 3
  • Minor trauma from footwear friction initiated the skin break 3

This triad accounts for >63% of diabetic foot ulcer pathways. 3

Secondary Diagnoses and Complications

Chronic venous insufficiency is evident from bilateral pitting edema (grade 2+, worse on left), hyperpigmentation, skin thickening, eczematous changes, and decreased hair growth—all classic venous stasis dermatitis findings. 1 The edema contributed to ulcer development in this case. 3

Undiagnosed type 2 diabetes mellitus is confirmed by random glucose 235 mg/dL plus classic symptoms (polyuria, polydipsia, nocturia). 4 The 3-year history of progressive bilateral neuropathy, family history (two siblings with type 2 diabetes), central obesity (waist circumference 102 cm), and likely prolonged hyperglycemia all support this diagnosis. 2

Possible heart failure with preserved ejection fraction is suggested by easy fatigability, dyspnea on moderate exertion (2 flights of stairs), orthopnea (sleeps with 2 pillows), presence of S3 gallop, and displaced apex beat (6th intercostal space). 5 Patients with diabetes and foot ulcers have significantly higher rates of coronary artery disease and cardiovascular comorbidities. 5

Possible coronary artery disease is indicated by occasional exertional chest tightness relieved by rest, multiple cardiovascular risk factors (hypertension, diabetes, former 25 pack-year smoker, central obesity), and family history of premature cardiac death. 5

Immediate Management Algorithm

1. Infection Control (First Priority)

Obtain deep tissue cultures via curettage or tissue biopsy after debridement—not superficial swabs—before initiating antibiotics. 1 The foul odor, purulent discharge, and surrounding cellulitis indicate polymicrobial infection likely involving both aerobic and anaerobic organisms. 6

Initiate empiric broad-spectrum antibiotics immediately after cultures, covering Staphylococcus aureus (including MRSA given healthcare exposure), Pseudomonas aeruginosa, and anaerobes. 1, 6 Common regimens include vancomycin plus piperacillin-tazobactam or a carbapenem. 1

Perform aggressive surgical debridement of all necrotic, devitalized tissue and callus to viable bleeding tissue. 2, 7 This is fundamental to healing and must be done urgently. 7

Assess for osteomyelitis with probe-to-bone test (negative here, but ulcer >2 cm and present >6 weeks increases risk), plain radiographs, and consider MRI if clinical suspicion remains high despite negative probe test. 1

2. Pressure Off-Loading (Equally Critical)

Mandate total contact casting or removable cast walker (if adherent) to completely eliminate weight-bearing pressure on the ulcer. 2, 7 Pressure mitigation is absolutely fundamental—ulcers will not heal without it. 7 The patient's occupation requires immediate work restriction or modification. 2

3. Vascular Assessment

Evaluate for peripheral arterial disease urgently, despite palpable pulses. 1 Obtain ankle-brachial index (ABI) and consider arterial duplex ultrasound. 7 The combination of infection with PAD markedly increases amputation risk, requiring early revascularization if ischemia is present. 1

4. Glycemic Control

Initiate insulin therapy immediately given random glucose 235 mg/dL, likely elevated HbA1c (expect >10% based on similar cohorts), and active infection causing stress hyperglycemia. 6, 8 Target glucose 140-180 mg/dL during acute infection. 8

Order HbA1c, comprehensive metabolic panel, lipid panel, and urinalysis to assess chronic glycemic control, renal function (creatinine clearance may be reduced), and screen for other microvascular complications. 5

5. Multidisciplinary Referral (Urgent)

Refer immediately to multidisciplinary diabetic foot team including podiatry, infectious disease, vascular surgery, and endocrinology. 2 Multidisciplinary care reduces major amputation rates from 4.4% to 3.2% (OR 0.40,95% CI 0.32-0.51). 2

Prognostic Considerations

This patient faces substantial morbidity and mortality risk. The 5-year mortality rate for diabetic foot ulcers is approximately 30%, with mortality rate of 231 deaths per 1000 person-years. 2 Major amputation carries >70% 5-year mortality. 2

High-risk features in this case include:

  • Likely prolonged uncontrolled diabetes (3-year neuropathy history suggests ≥10-15 years disease duration) 6, 5
  • Moderate-to-severe infection with systemic symptoms (fever, malaise) 1
  • Multiple cardiovascular comorbidities (hypertension, possible heart failure, possible CAD) 5
  • Ulcer present 6 weeks with progressive enlargement despite treatment attempts 2
  • Elevated admission glucose (third tertile ACG ratio associated with increased MODS, MACE, and mortality) 8

Even with optimal treatment, only 30-40% of diabetic foot ulcers heal at 12 weeks, with 42% recurrence at 1 year and 65% at 5 years. 2

Critical Pitfalls to Avoid

Do not rely on pain severity to gauge infection severity—peripheral neuropathy masks pain, and this patient rates pain only 2-3/10 despite moderate-to-severe infection. 1

Do not delay antibiotics for culture results—initiate empiric therapy immediately after obtaining proper specimens. 1

Do not accept "partial" off-loading—complete pressure elimination is mandatory; patient education about non-weight-bearing is insufficient without mechanical devices. 2, 7

Do not overlook cardiovascular evaluation—the S3 gallop, orthopnea, exertional symptoms, and displaced apex warrant urgent cardiology referral given extremely high cardiovascular mortality in this population. 5

Do not assume adequate perfusion based on palpable pulses alone—formal vascular studies are mandatory. 1, 7

Related Questions

What is the appropriate management for a 62‑year‑old male with diabetic peripheral neuropathy, venous stasis changes, a 3–4 cm non‑healing left medial ankle ulcer with serous‑purulent discharge and intermittent low‑grade fever, hypertension, uncontrolled hyperglycemia, and grade 2+ pitting edema of the lower legs?
To whom should a patient with diabetic neuropathy be referred for comprehensive management?
What are the treatment options for diabetic neuropathy?
What is the management of diabetic (Dm) foot pain, numbness, and nocturnal hotness?
What is the diagnosis and treatment for a patient with a 1-month history of flaking skin in a glove and stocking pattern, suggestive of peripheral neuropathy, diabetes, or vitamin deficiencies?
What is the recommended treatment and dosing regimen for hyperacidity?
What is the appropriate Unasyn (ampicillin + sulbactam) dosing for a patient with possible otitis media versus acute bacterial meningitis?
In a patient with vitamin D deficiency (25‑hydroxyvitamin D ≈12 ng/mL) who is receiving weekly cholecalciferol 60,000 IU, is it appropriate to add a daily 1,000 IU vitamin D supplement together with calcium, vitamin K2 (menaquinone), and magnesium?
What is the diagnosis in an asymptomatic woman with a suppressed thyroid‑stimulating hormone (TSH) < 0.03 µIU/mL, normal free thyroxine (free T4) 11.3 pmol/L, and normal free triiodothyronine (free T3) 7.15 pmol/L?
What is the recommended Unasyn (ampicillin‑sulbactam) dosing regimen for treating acute otitis media in children?
What is the recommended dosing of Unasyn (ampicillin‑sulbactam) for an adult with acute otitis media?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.